Hemostemix (HEM) Stock Chart & Stock Price History C$0.14 +0.01 (+3.85%) As of 11:24 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesInsider TradesBuy This Stock Hemostemix Stock Price Performance The Hemostemix (HEM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 200.00%, with a year-to-date return of 12.50%. In the past month, the stock has increased 50.00%, reflecting recent market activity. As of the latest close, Hemostemix traded at C$0.13 with a market cap of C$18.95 million and volume of 430,289 shares. Five years ago, the stock traded at C$0.01, representing a 1,250.00% increase over that period. At the time, it had a market cap of C$9.07 million and a volume of 8.22 million shares. Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+35.00%1 Month Performance+50.00%3 Month Performance-22.86%Year-To-Date Performance+12.50%1 Year Performance+200.00%5 Year Performance+1,250.00% HEM Stock Chart for Wednesday, May, 21, 2025 HEM Chart by TradingView Hemostemix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2025C$0.10C$0.13+30.00%C$0.15C$0.10430,289 shsC$18.95 million05/19/2025C$0.10C$0.10C$0.10C$0.10224,094 shsC$14.57 million05/16/2025C$0.10C$0.10+5.26%C$0.10C$0.10224,094 shsC$14.57 million05/15/2025C$0.10C$0.10C$0.10C$0.09147,000 shsC$13.84 million05/14/2025C$0.10C$0.10C$0.10C$0.0990,434 shsC$13.84 million05/13/2025C$0.10C$0.10C$0.10C$0.0990,434 shsC$13.84 million05/12/2025C$0.10C$0.10C$0.10C$0.09263,377 shsC$13.84 million05/09/2025C$0.10C$0.10C$0.10C$0.1051,200 shsC$13.84 million05/08/2025C$0.10C$0.10C$0.10C$0.105,600 shsC$13.84 million05/07/2025C$0.10C$0.10C$0.10C$0.1069,450 shsC$13.84 million Get the Latest News and Ratings for HEM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. 05/06/2025C$0.10C$0.10C$0.10C$0.09282,210 shsC$13.84 million05/05/2025C$0.10C$0.10C$0.10C$0.1099,000 shsC$13.84 million05/02/2025C$0.10C$0.10C$0.10C$0.1024,272 shsC$13.84 million05/01/2025C$0.09C$0.10+5.56%C$0.10C$0.09249,000 shsC$13.84 million04/30/2025C$0.10C$0.09-5.26%C$0.09C$0.0978,657 shsC$13.12 million04/29/2025C$0.09C$0.10+5.56%C$0.10C$0.09109,200 shsC$13.84 million04/28/2025C$0.10C$0.09-5.26%C$0.09C$0.092,500 shsC$13.12 million04/25/2025C$0.10C$0.10C$0.10C$0.1022,000 shsC$13.84 million04/24/2025C$0.10C$0.10C$0.10C$0.09204,800 shsC$13.84 million04/23/2025C$0.09C$0.10+5.56%C$0.10C$0.09141,277 shsC$13.84 million04/22/2025C$0.09C$0.09C$0.09C$0.09156,000 shsC$13.12 million04/21/2025C$0.10C$0.09-5.26%C$0.09C$0.09287,000 shsC$13.12 million Related Companies Oncolytics Biotech Stock Price Chart Helix BioPharma Stock Price Chart Microbix Biosystems Stock Price Chart Devonian Health Group Stock Price Chart Sirona Biochem Stock Price Chart BriaCell Therapeutics Stock Price Chart Kane Biotech Stock Price Chart Resverlogix Stock Price Chart Innovotech Stock Price Chart Quest PharmaTech Stock Price Chart Receive HEM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:HEM) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
